222 related articles for article (PubMed ID: 32664447)
1. Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.
Mendes A; Jühlen R; Bousbata S; Fahrenkrog B
Cells; 2020 Jul; 9(7):. PubMed ID: 32664447
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.
Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR
J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715
[TBL] [Abstract][Full Text] [Related]
3. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
[TBL] [Abstract][Full Text] [Related]
4. Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.
Oka M; Mura S; Yamada K; Sangel P; Hirata S; Maehara K; Kawakami K; Tachibana T; Ohkawa Y; Kimura H; Yoneda Y
Elife; 2016 Jan; 5():e09540. PubMed ID: 26740045
[TBL] [Abstract][Full Text] [Related]
5. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.
Sarma NJ; Yaseen NR
J Biol Chem; 2011 Nov; 286(45):38989-9001. PubMed ID: 21937451
[TBL] [Abstract][Full Text] [Related]
6. Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.
Sarma NJ; Yaseen NR
PLoS One; 2013; 8(6):e67032. PubMed ID: 23840580
[TBL] [Abstract][Full Text] [Related]
7. The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.
Lavau CP; Aumann WK; Sze SK; Gupta V; Ripple K; Port SA; Kehlenbach RH; Wechsler DS
PLoS One; 2020; 15(4):e0232036. PubMed ID: 32343715
[TBL] [Abstract][Full Text] [Related]
8. Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.
Oka M; Otani M; Miyamoto Y; Oshima R; Adachi J; Tomonaga T; Asally M; Nagaoka Y; Tanaka K; Toyoda A; Ichikawa K; Morishita S; Isono K; Koseki H; Nakato R; Ohkawa Y; Yoneda Y
Cell Rep; 2023 Aug; 42(8):112884. PubMed ID: 37516964
[TBL] [Abstract][Full Text] [Related]
9. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
10. The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype.
Vaz M; Fahrenkrog B
Cells; 2021 Oct; 10(11):. PubMed ID: 34831074
[TBL] [Abstract][Full Text] [Related]
11. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
[TBL] [Abstract][Full Text] [Related]
12. Nucleoporins and nucleocytoplasmic transport in hematologic malignancies.
Takeda A; Yaseen NR
Semin Cancer Biol; 2014 Aug; 27():3-10. PubMed ID: 24657637
[TBL] [Abstract][Full Text] [Related]
13. Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with
Mendes A; Jühlen R; Martinelli V; Fahrenkrog B
Oncotarget; 2020 Sep; 11(36):3371-3386. PubMed ID: 32934780
[TBL] [Abstract][Full Text] [Related]
14. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
Funasaka T; Nakano H; Wu Y; Hashizume C; Gu L; Nakamura T; Wang W; Zhou P; Moore MA; Sato H; Wong RW
Cell Cycle; 2011 May; 10(9):1456-67. PubMed ID: 21467841
[TBL] [Abstract][Full Text] [Related]
15. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells.
Ghannam G; Takeda A; Camarata T; Moore MA; Viale A; Yaseen NR
J Biol Chem; 2004 Jan; 279(2):866-75. PubMed ID: 14561764
[TBL] [Abstract][Full Text] [Related]
16. Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
Fahrenkrog B; Martinelli V; Nilles N; Fruhmann G; Chatel G; Juge S; Sauder U; Di Giacomo D; Mecucci C; Schwaller J
PLoS One; 2016; 11(3):e0152321. PubMed ID: 27031510
[TBL] [Abstract][Full Text] [Related]
17. The Oncogenic Fusion Proteins SET-Nup214 and Sequestosome-1 (SQSTM1)-Nup214 Form Dynamic Nuclear Bodies and Differentially Affect Nuclear Protein and Poly(A)+ RNA Export.
Port SA; Mendes A; Valkova C; Spillner C; Fahrenkrog B; Kaether C; Kehlenbach RH
J Biol Chem; 2016 Oct; 291(44):23068-23083. PubMed ID: 27613868
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the NUP98-CCDC28A fusion protein.
Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
[TBL] [Abstract][Full Text] [Related]
19. Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15).
Fujino T; Suzuki A; Ito Y; Ohyashiki K; Hatano Y; Miura I; Nakamura T
Blood; 2002 Feb; 99(4):1428-33. PubMed ID: 11830496
[TBL] [Abstract][Full Text] [Related]
20. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
Pineault N; Abramovich C; Ohta H; Humphries RK
Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]